As COVID-19 cases continue to surge around the world, the debate is raging over whether patents on existing vaccines should be waived. But the global community could view patent waivers as just one of many available tools for speeding up vaccine delivery worldwide.
China pays U.S. scientists for their innovations in exchange for money and access to research laboratories and speaking and publication opportunities. They require the researchers to keep these agreements secret from their employers or the U.S. government. Perhaps it is time to codify scientific transparency into law.
When a COVID-19 vaccine is developed, many in rich countries may be able to afford it while the poor and uninsured may not. The time to plan for equitable access, financing, intellectual property rights, and global production is now.
Researchers assessed intellectual property (IP) support at the U.S. Department of Homeland Security (DHS) and its components and found underused opportunities but also issues that expose programs to substantial risk.
Since the early 2000s, relations between China and Israel have expanded in areas like diplomacy, trade, investment, construction, educational partnerships, scientific cooperation, and tourism. What challenges does the relationship pose for Israel and the United States?
The EU has embarked on negotiations with the U.S. on the TTIP, which shares some of ACTA's goals. This time, though, the European Commission is seeking to make the talks more transparent by publishing a series of position papers on key issues very early on in the process. This is a step in the right direction toward an agreement that will have economic benefits for a net-exporting region of intellectual property such as the EU.
Open innovation is often suggested as a solution to enhance productivity in under-performing areas of research. Now, the strengths and weaknesses of a new open innovation model in drug discovery have been evaluated.
An independent evaluation of the Structural Genomics Consortium (SGC) examined the strengths and weaknesses of its efforts to support drug discovery efforts through a unique, open access model of public-private collaboration.
This report summarises the results of an independent evaluation of the Structural Genomics Consortium, an open access model of public-private collaboration, conducted by RAND Europe with the Institute on Governance.
Efforts to come to grips with intellectual property rights aren't dying down after the European Parliament voted down the Anti-Counterfeiting Trade Agreement (ACTA) last summer. Indeed, the need for evidence of the scale and impact of counterfeiting has only become more pressing. A RAND Europe report points to a potential solution and has already been dubbed "tech's Holy Grail" by a Fortune.com contributor.
A new method for estimating the costs of counterfeiting was published today by RAND Europe. The approach uses market data to estimate the effects of intellectual property rights infringements, such as counterfeit products, on sales of legitimate goods.
Globalization, integrated markets, and the Internet economy have contributed to the rise in IPR infringements. RAND developed a methodology based on economic theory to contribute to quantifying the scope, scale, and impact of IPR infringements, such as counterfeiting, unauthorized downloads, and piracy.
This report examines the impact of intellectual property rights in developing countries, in the context of the World Trade Organization's Agreement on Trade-Related Intellectual Property Rights (TRIPS) and the development of TRIPS-plus standards.
This Note aims to improve understanding of how new information and communications technologies may affect the economic system in which knowledge-based products and services are produced, packaged, distributed, and used.